Charles W. Bolten

432 total citations
9 papers, 313 citations indexed

About

Charles W. Bolten is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Charles W. Bolten has authored 9 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Physiology and 2 papers in Pharmacology. Recurrent topics in Charles W. Bolten's work include Peroxisome Proliferator-Activated Receptors (5 papers), Adipose Tissue and Metabolism (4 papers) and Metabolism, Diabetes, and Cancer (3 papers). Charles W. Bolten is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (5 papers), Adipose Tissue and Metabolism (4 papers) and Metabolism, Diabetes, and Cancer (3 papers). Charles W. Bolten collaborates with scholars based in United States, Germany and Australia. Charles W. Bolten's co-authors include Chunsheng Xia, Xiao Hu, Maria Payne, Jessica D. Dietz, Sarah Du, John W. Funder, James R. Blinn, Sudhirdas Prayaga, Suzhen Li and Deepak S. Lala and has published in prestigious journals such as Hypertension, American Journal of Physiology-Cell Physiology and Molecular Endocrinology.

In The Last Decade

Charles W. Bolten

9 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles W. Bolten United States	7	140	104	101	43	38	9	313
Yang Jie-ren China	16	178 1.3×	75 0.7×	69 0.7×	44 1.0×	46 1.2×	27	536
Ellen V. Cryan United States	10	214 1.5×	160 1.5×	115 1.1×	37 0.9×	64 1.7×	13	426
Maya S. Gowri United States	10	127 0.9×	155 1.5×	97 1.0×	44 1.0×	57 1.5×	10	450
Sahar E. El-Swefy Egypt	14	77 0.6×	56 0.5×	65 0.6×	52 1.2×	80 2.1×	25	502
Helena Quesada Spain	12	151 1.1×	60 0.6×	133 1.3×	26 0.6×	64 1.7×	12	440
Sheng-kai Yan China	7	94 0.7×	100 1.0×	82 0.8×	39 0.9×	60 1.6×	12	419
Xinglei Zhu China	12	175 1.3×	66 0.6×	48 0.5×	81 1.9×	21 0.6×	20	478
Benjamine Geeraert Belgium	11	178 1.3×	51 0.5×	80 0.8×	44 1.0×	96 2.5×	11	447
Anthony Dalpiaz United States	6	134 1.0×	292 2.8×	129 1.3×	43 1.0×	78 2.1×	8	651

Countries citing papers authored by Charles W. Bolten

Since Specialization

Citations

This map shows the geographic impact of Charles W. Bolten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles W. Bolten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles W. Bolten more than expected).

Fields of papers citing papers by Charles W. Bolten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles W. Bolten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles W. Bolten. The network helps show where Charles W. Bolten may publish in the future.

Co-authorship network of co-authors of Charles W. Bolten

This figure shows the co-authorship network connecting the top 25 collaborators of Charles W. Bolten. A scholar is included among the top collaborators of Charles W. Bolten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles W. Bolten. Charles W. Bolten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Brunmair, Barbara, et al.. (2011). Lipophilicity as a determinant of thiazolidinedione action in vitro: findings from BLX-1002, a novel compound without affinity to PPARs. American Journal of Physiology-Cell Physiology. 300(6). C1386–C1392. 5 indexed citations

Dietz, Jessica D., Sarah Du, Charles W. Bolten, et al.. (2008). A Number of Marketed Dihydropyridine Calcium Channel Blockers Have Mineralocorticoid Receptor Antagonist Activity. Hypertension. 51(3). 742–748. 103 indexed citations

Bolten, Charles W., William Graham McDonald, Nicholas R. Staten, et al.. (2007). Insulin Sensitizing Pharmacology of Thiazolidinediones Correlates with Mitochondrial Gene Expression rather than Activation of PPARγ. 1. 12 indexed citations

Bolten, Charles W., William Graham McDonald, Nicholas R. Staten, et al.. (2007). Insulin sensitizing pharmacology of thiazolidinediones correlates with mitochondrial gene expression rather than activation of PPAR gamma.. PubMed. 1. 73–82. 33 indexed citations

Bolten, Charles W., Maria Payne, William Graham McDonald, et al.. (2007). Thiazolidinediones inhibit the progression of established hypertension in the Dahl salt-sensitive rat. Diabetes and Vascular Disease Research. 4(2). 117–123. 12 indexed citations

Hu, Xiao & Charles W. Bolten. (2006). Adrenal corticosteroids, their receptors and hypertension. Drug Development Research. 67(12). 871–883. 4 indexed citations

Li, Yu, Charles W. Bolten, Balkrishen Bhat, et al.. (2002). Induction of Human Liver X Receptor α Gene Expression Via an Autoregulatory Loop Mechanism. Molecular Endocrinology. 16(3). 506–514. 80 indexed citations

Kevekordes, Sebastian, et al.. (2001). Micronucleus formation in human lymphocytes and in the metabolically competent human hepatoma cell line Hep-G2: results with 15 naturally occurring substances.. PubMed. 21(1A). 461–9. 54 indexed citations

Kevekordes, Sebastian, et al.. (1998). Genotoxicity of polycyclic musk fragrances in the sister-chromatid exchange test.. PubMed. 18(1A). 449–52. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact